Will trials show DDL-920 effectiveness in humans?

Prediction market on manifold. Will this small molecule drug replicate from mouse testing to humans? A therapeutic small molecule enhances γ-oscillations and improves cognition/memory in Alzheimer’s disease model mice | PNAS Definitely resolves 'yes' if it ends up FDA approved, but much more modest (e.g. pre-clinical) studies may also be reason to resolve either way. Not trading myself, because not being a biologist it will be already hard enough to navigate.

Liquidity: $1,070. Resolves: 8/16/2029.